There is decreased risk for CV events and mortality in patients with cardiac autonomic neuropathy that receive intensive glycemic treatment.

EU chief, Trump had 'good exchange' by phone Sunday CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S.

The Komfo Anokye Teaching Hospital is seeking the urgent prioritization and construction of a catheterisation laboratory after losing one of its critical medical staff who suffered a heart attack.

New 10-year data from the DANAMI-3-PRIMULTI trial show long-term benefits of complete revascularization for patients with STEMI and multivessel disease compared with treatment of the infarct-related ...

A report on the rising incidence of sudden cardiac deaths among the youth will be submitted by a 12-member technical ...

Health Minister says all corporate and private companies will be directed to mandatorily provide annual health screening for ...

A new study published in the Journal of American Medical Association showed no advantage to immediate coronary angiography ...

The Scott Lynn Kilburg cause of death has suddenly become one of the most searched and talked about topics online, and ...

Just a dozen patients have undergone the new treatment that uses electrical pulses to target problem areas inside the heart.

Surviving a cardiac arrest can save your life—but it can also drain your finances. From ICU stays to costly procedures like ...

In STEMI-induced cardiogenic shock, a microaxial flow pump can unload the heart by reducing native cardiac output and ...

The history, ECG, age, risk factors, and troponin (HEART) score was developed as a rapid risk stratification tool. It has ...